Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H26N2O2 |
Molecular Weight | 326.4326 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(C1CCCCC1)N2CC3N(CCCC4=C3C=CC=C4)C(=O)C2
InChI
InChIKey=LGUDKOQUWIHXOV-UHFFFAOYSA-N
InChI=1S/C20H26N2O2/c23-19-14-21(20(24)16-8-2-1-3-9-16)13-18-17-11-5-4-7-15(17)10-6-12-22(18)19/h4-5,7,11,16,18H,1-3,6,8-10,12-14H2
Epsiprantel is a veterinary drug which is used as an antiparasitic agent. Epsiprantel in tablets (Cestex) is indicated for the removal of tapeworms in the cat (Dipylidium caninumand Taenia taeniaeformis) and dog (Dipylidium caninum and Taenia pisiformis). Epsiprantel acts directly on the tapeworm. Since it is minimally absorbed following oral administration, epsiprantel remains at the site of action within the gastrointestinal tract. Due to digestive process, tapeworm fragments or proglottids may not be readily visible in the stool. Epsiprantel is not a cholinesterase inhibitor. During the course of clinical field studies, Cestex was administered concurrently with diethylcarbamazine citrate (dogs only), anti-inflammatory agents, insecticides, and nematocides with no drug incompatibilities noted. The mechanism of action of epsiprantel appears to be similar to that of praziquantel, a drug that disrupts the regulation of calcium and other cations. Tetanic muscle contraction and paralysis occurs in the parasite, and the tegument becomes vacuolized
Approval Year
Sample Use Guides
veterinary use:
cats: 1.25 mg/lb of body weight
dogs: 2.5 mg/lb of body weight
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/1780591
epsiprantel at a concentration of 10 ug ml-1 caused tegumental damage and death of protoscoleces, juveniles (seven-day-old) and adult (37-day-old) Echinococcus granulosus.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QP52AA04
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
||
|
CFR |
21 CFR 520.816
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
||
|
WHO-VATC |
QP52AA54
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
24285
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | RxNorm | ||
|
72026
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | |||
|
98123-83-2
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | |||
|
0C1SPQ0FSR
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | |||
|
0C1SPQ0FSR
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | |||
|
C75217
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | |||
|
m4964
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000084576
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | |||
|
DTXSID3057858
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | |||
|
EPSIPRANTEL
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | |||
|
SUB06590MIG
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | |||
|
121654-56-6
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
SUPERSEDED | |||
|
CHEMBL64979
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY | |||
|
6103
Created by
admin on Fri Dec 15 15:54:17 GMT 2023 , Edited by admin on Fri Dec 15 15:54:17 GMT 2023
|
PRIMARY |
ACTIVE MOIETY